Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07158086

Molecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA Profiling

Molecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA Profiling: the BIOCARDIUM-HF Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The main objective of the study is to achieve a comprehensive phenotyping of patients with heart failure, combining detailed clinical characterization with in-depth molecular profiling. By integrating clinical data with cutting-edge multi-omics techniques (including transcriptomics, epigenomics, and proteomics), this research aims to identify molecular signatures, particularly non-coding RNAs (ncRNAs), that are linked to the onset and progression of HF. Through advanced molecular profiling of biological samples and the analysis of clinical parameters, including advanced imaging, hemodynamic profiling, and biomarker analysis, the study will contribute to the deep phenotyping of HF patients. The secondary objective aims to uncover potential biomarkers that may serve as predictive indicators of disease progression and identify novel therapeutic targets, offering promising avenues for future treatments in this challenging patient population.

Conditions

Timeline

Start date
2025-11-01
Primary completion
2030-11-30
Completion
2031-11-30
First posted
2025-09-05
Last updated
2025-09-10

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT07158086. Inclusion in this directory is not an endorsement.